retatrutide peptidesciences What Is Retatrutide? Complete Research Guide to This Triple Agonist Peptide (2026) Retatrutide 25mg – Research Peptide

You can visit the NovoCare website to check if you qualify and start the application process, or call 1-866-310-7549

Retatrutide (developmental code: LY3437943) is an investigational synthetic peptide developed by Eli Lilly and Company

That extra lever is why researchers call retatrutide a "triple G" agonist

care team beside you and Medicare helping cover the cost of care

We freeze-dry (lyophilize) the peptide into a uniform white powder

Osteoarthritis usually develops from cartilage wear and joint degeneration over time, while rheumatoid arthritis is an autoimmune condition that causes inflammation inside the joints